Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 111.20
-5.00 (-4.30%)
May 13, 2025, 5:29 PM CET
Devyser Diagnostics AB Revenue
Devyser Diagnostics AB had revenue of 54.80M SEK in the quarter ending March 31, 2025, with 8.09% growth. This brings the company's revenue in the last twelve months to 221.00M, up 22.44% year-over-year. In the year 2024, Devyser Diagnostics AB had annual revenue of 216.90M with 28.12% growth.
Revenue (ttm)
221.00M
Revenue Growth
+22.44%
P/S Ratio
8.33
Revenue / Employee
1.84M
Employees
121
Market Cap
1.84B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |